Asklepios Fachkliniken München-Gauting

Recent papers from Asklepios Fachkliniken München-Gauting

1. FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLCClinical Cancer Research · 2026
2. Independent Component Analysis for Non‐Contrast‐Enhanced Free‐Breathing Pulmonary Ventilation and Perfusion MRIMagnetic Resonance in Medicine · 2026
3. Genetics and Genomics of Pulmonary Arterial HypertensionJournal of the American College of Cardiology · 2009
4. Health-Related Quality of Life in Children with X-Linked Hypophosphatemia Treated with Burosumab: Real-World Data from a German-Swiss StudyCalcified Tissue International · 2026
5. Non-small cell lung cancer with synchronous oligometastatic disease at the time of initial diagnosis. Impact of multimodal treatment on prognosisLung Cancer · 2026
6. Prognostic Factors and Survival Outcomes in Resectable Thoracic Soft Tissue and Bone SarcomasCancers · 2026
7. First-line (1L) olomorasib + pembrolizumab in patients with KRAS G12C–mutant advanced NSCLC, and PD-L1 expression 0-49%, from the dose optimization cohorts of LOXO-RAS-20001 and SUNRAY-01.Journal of Clinical Oncology · 2026
8. C23-03 Heterogeneity Matters Only in Lower Lobe Endoscopic Lung Volume Reduction With ValvesAmerican Journal of Respiratory and Critical Care Medicine · 2026
9. Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumabJournal of Bone and Mineral Research · 2026
10. 422P Primary lung tumour laterality, molecular characteristics, and prognostic impact in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) in the phase III CASPIAN trialESMO Open · 2026
11. Same site recurrence following standardized high ligation and stripping of the great saphenous vein – 5‐year results of the LaVaCro trialJDDG Journal der Deutschen Dermatologischen Gesellschaft · 2026
12. Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, EGFR Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY TrialJTO Clinical and Research Reports · 2026
13. Sex differences in efficacy and adverse events following bronchoscopic thermal vapour ablation for severe emphysema: results from a multinational real-world registryBMJ Open Respiratory Research · 2026
14. Lung volume reduction coil treatment for patients with severe heterogeneous emphysema, a multicenter feasibility trialEuropean Respiratory Journal · 2011
15. Is surgery with curative intent feasible in old and very old patients with non-small cell lung cancer? – Experience of a certified lung cancer center over one decadeLangenbeck s Archives of Surgery · 2026
16. Exploring Thoracic Radiotherapy in Metastatic NSCLC: A Retrospective Review in the Era of Immunotherapy and Targeted TherapiesClinical Lung Cancer · 2026
17. Peri-interventional antibiotic prophylaxis in endoscopic valve implantation for lung volume reduction in COPD patients: results from a German multicenter observational cohortInfection · 2026
18. Lung Cancer patients from Oncology and Thoracic Surgery units show similar acceptance of telemedicine servicesInterdisciplinary CardioVascular and Thoracic Surgery · 2026
19. Zipalertinib—A Novel Treatment Opportunity for Non-Small Cell Lung Cancers with Exon 20 Insertions and Uncommon EGFR MutationsCancers · 2026
20. Tuberculosis diagnosis and the complete drug resistance pattern from a single sample within a single day by use of a composite platform of MAX MDR-TB and AmPORE-TBJournal of Clinical Microbiology · 2026